Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Furikangzheng Medical Technology Research Institute is a specialized pharmaceutical research and development organization based in Beijing, China. Established in 2002, the institute focuses on the synthesis of chemical drugs, formulation development, and the provision of technical services for generic drug consistency evaluation. It operates primarily as a Contract Research Organization (CRO) and technology transfer partner, assisting pharmaceutical companies in navigating the complexities of drug registration and manufacturing. The institute's expertise spans various therapeutic categories, including cardiovascular, endocrine, and central nervous system disorders. By bridging laboratory innovation with industrial application, Furikangzheng plays a significant role in the Chinese domestic pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Furikangzheng Medical Technology Research Institute.